As of Feb 11, 2025, the Novanta stock's P/E ratio is 87.74. This results from the current EPS of $1.67 and stock price of $146.53. The PE ratio has decreased by 6% from the past four quarters average of 93.4.
The PE ratio of Novanta has averaged 70.47 over the last ten years. The current price-to-earnings ratio of 87.74 is 25% more than the historical average. In the past ten years, NOVT's PE ratio reached its highest point in the Mar 2018 quarter at 153.38, when the stock price was $52.15 and the EPS was $0.34. The lowest point was recorded in the Dec 2015 quarter, when it reached 13.22 with a price of $13.62 and an EPS of $1.03.
Maximum annual increase: 258.47% in 2013
Maximum annual decrease: -47.4% in 2022
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2023 | 82.96 | 27.01% | $168.41 | $2.03 |
2022 | 65.32 | -47.4% | $135.87 | $2.08 |
2021 | 124.18 | 33.4% | $176.33 | $1.42 |
2020 | 93.09 | 22.1% | $118.22 | $1.27 |
2019 | 76.24 | 76.69% | $88.44 | $1.16 |
2018 | 43.15 | -1.62% | $63 | $1.46 |
2017 | 43.86 | 31.59% | $50 | $1.14 |
2016 | 33.33 | 152.12% | $21 | $0.63 |
2015 | 13.22 | N/A | $13.62 | $1.03 |
2014 | N/A | N/A | $14.72 | -$0.7 |
2013 | 53.52 | 258.47% | $11.24 | $0.21 |
2012 | 14.93 | 26.96% | $8.66 | $0.58 |
2011 | 11.76 | N/A | $10.23 | $0.87 |
2010 | N/A | N/A | $10.58 | -$0.03 |
2009 | N/A | N/A | $2.61 | -$4.48 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Sep 2024 | 105.67 | 12.08% | $176.47 | $1.67 |
Jun 2024 | 94.28 | 4.12% | $163.11 | $1.73 |
Mar 2024 | 90.55 | 9.15% | $174.77 | $1.93 |
Dec 2023 | 82.96 | 22.04% | $168.41 | $2.03 |
Sep 2023 | 67.98 | -20.61% | $143.44 | $2.11 |
Jun 2023 | 85.63 | 10.88% | $184.1 | $2.15 |
Mar 2023 | 77.23 | 18.23% | $159.09 | $2.06 |
Dec 2022 | 65.32 | 15.22% | $135.87 | $2.08 |
Sep 2022 | 56.69 | -15.13% | $115.65 | $2.04 |
Jul 2022 | 66.8 | -22.91% | $119.58 | $1.79 |
Apr 2022 | 86.65 | -30.22% | $141.24 | $1.63 |
Dec 2021 | 124.18 | 12.59% | $176.33 | $1.42 |
Oct 2021 | 110.29 | -0.44% | $153.3 | $1.39 |
Jul 2021 | 110.78 | 1.86% | $137.37 | $1.24 |
Apr 2021 | 108.76 | 16.83% | $134.86 | $1.24 |
Currently, NOVT's PE ratio is above the 3 and 10-year averages, but it is lower than the 5-year average.
Stock name | PE ratio | Market cap |
---|---|---|
NOVT Novanta Inc | 87.74 | $5.26B |
OBIO Orchestra BioMed Holdings Inc | N/A | $204.51M |
OM Outset Medical Inc | N/A | $41.76M |
NOVT stock has a price to earnings ratio of 87.74 as of Feb 11, 2025.
The average PE ratio for NOVT stock over the past 3 years is 79.98.
The average PE ratio for NOVT stock over the past 5 years is 87.82.
The highest quarterly PE ratio in the last ten years has been 153.38 and it was in the Mar 2018 quarter.
NOVT's price to earnings ratio is currently 25% above its 10-year historical average.
NOVT's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Feb 11, 2025), Novanta's stock price is $146.53. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $1.67. Therefore, Novanta's price to earnings ratio for today is 87.74. PE RATIO(87.74) = STOCK PRICE($146.53) / TTM EPS($1.67)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.